The Drug Quality and Security Act (DQSA) was signed into law in 2013
503B Facilities were created to produce sterile human compounded drugs for in-hospital/clinic use

As states began adopting laws pertaining to clinic-use veterinary compounding, the need was realized to build a 503B

Planning for Atlas Pharmaceuticals began in March 2016

Purpose is to provide cGMP quality sterile and non-sterile products for practitioners for use in their facilities.

Eaton Veterinary Pharmaceuticals, Inc., owner of Roadrunner Pharmacy, Inc., has been the industry leader in providing sterile compounded medications to veterinary hospitals for years. While regulations prevent any differentiation for quality control between human and veterinary compounding, we have taken pride in leading the compounding industry for many years in both quality and service. Most recently, our company formed Atlas Pharmaceuticals. We combined the years of experience from our seasoned staff of nationally certified technicians, pharmacists, and chemists with the construction of a new first class 503B facility dedicated to the production of both sterile and non-sterile compounds for use in human hospitals and other health care facilities. Our production will be devoted to compounded medications that are either unavailable, back-ordered, or uniquely customized and yet produced to the same quality standards as pharmaceutical manufacturing.

Contact Information

711 E. Carefree Hwy Ste. 207
Phoenix, AZ 85085
United States


Total FundingEmployeesLast Funding DateStatus